|
Tuesday, 08/03/2010
|
A Multilevel Modeling Approach to Investigating Treatment Effect Variability in Randomized Longitudinal Experiments
Joseph Rausch, University of Cincinnati College of Medicine/Cincinnati Children's Hospital
9:15 AM
|
Estimation of Treatment Effect Following a Clinical Trial with Adaptive Design
Xiaolong Luo, Celgene Corporation; Peter Ouyang, Celgene Corporation
9:20 AM
|
A New Method for Combining Experimental and Observational Data to Estimate Population Treatment Effects
Richard Grieve, London School of Hygiene and Tropical Medicine; Erin Hartman, University of California, Berkeley; Jasjeet Sekhon, University of California, Berkeley
11:05 AM
|
Using IV with Subjective Assumptions to Construct Treatment Effect Bounds on Continuous Outcomes in Observational Studies
Joseph W. Hogan, Brown University; Tao Liu, Brown University
2:05 PM
|
Nonparametric Test of Treatment Effects When Design Plans Are Combined
Yvonne M. Zubovic, Indiana University Purdue University Fort Wayne; Chand Chauhan, Indiana University Purdue University Fort Wayne
2:20 PM
|
Regression Adjustment and Stratification by Propensity Score in Treatment Effect Estimation
Jessica Amelia Myers, Johns Hopkins Bloomberg School of Public Health; Thomas Louis, Johns Hopkins Bloomberg School of Public Health
2:25 PM
|
Evaluating Distributional Treatment Effect in Observational Studies
Jing Cheng, University of Florida
2:30 PM
|
Compare Sensitivity of Multiple Measures in Discerning a Treatment Effect
Hongwei Wang, Merck & Co., Inc.; Arvind K. Shah, Merck Research Laboratories
2:35 PM
|
Confidence Intervals for the Selected Treatment Effect in Multistage Adaptive Designs
Ionut Bebu, Georgetown University Medical Center; Vladimir Dragalin, Pfizer Inc.; George Luta, Georgetown University
3:20 PM
|
Evaluation of Regional Treatment Effect in a Multiregional Clinical Trial
Yi Tsong, CDER/FDA; W-J Chang, National Health Research Institutes, Taiwan; Chin-Fu Hsiao, National Health Research Institutes, Taiwan; Hsiao-Hui Tsou, National Health Research Institutes, Taiwan
3:25 PM
|
|
Wednesday, 08/04/2010
|
The Distributional Efficacy of Collaborative Learning Recitation Sessions on Student Outcomes
James K. Self, Indiana University; Kim P. Huynh, Indiana University; David T. Jacho-Chavez, Indiana University
8:50 AM
|
Semiparametric Estimator for Differences in Restricted Mean Lifetimes in Observational Studies
Min Zhang, University of Michigan; Douglas E. Schaubel, University of Michigan
8:55 AM
|
Assessing Treatment Effect in Clinical Trials with Dichotomous Endpoints
Gang Jia, Merck & Co., Inc.
9:20 AM
|
A 'Paradox' in the Use of an ANCOVA Model in Determination of Treatment Effect in Clinical Trials
Chi-Hse Teng, Amylin Pharmaceuticals; Larry Z. Shen, Amylin Pharmaceuticals; Ping Yan, Amylin Pharmaceuticals
9:35 AM
|
Should I Use Gain Scores to Determine Treatment Effect from a Pretest-Posttest Design?: A Simulation Study
Michael Posner, Villanova University; AnneMichele Millar, Mount Saint Vincent University; Philip Yates, California State Polytechnic University, Pomona
11:15 AM
|
Effect of Patient Allocation Schemes on the Power of a Test for Treatment Effect
Fanni Natanegara, Eli Lilly and Company; Christel Faes, Hasselt University; Geert Molenberghs, I-BioStat; Craig Mallinckrodt, Eli Lilly and Company
3:35 PM
|
|
Thursday, 08/05/2010
|
A Hybrid Method in Combining Treatment Effects from Matched and Unmatched Studies
Jinyoung Byun, The University of Texas School of Public Health; Dejian Lai, The University of Texas School of Public Health; Sheng Luo, The University of Texas School of Public Health; Robert Hardy, The University of Texas School of Public Health
9:05 AM
|
Estimation of Average Treatment Effect in Causal Inference Using Exponential Tilting Models
Ming Zhou, Iowa State University; Jae-Kwang Kim, Iowa State University
9:35 AM
|
Considerations for Design and Data Analysis of Adaptive Superiority/Noninferiority Cardiovascular Trials
Hui Quan, sanofi-aventis; Mingyu Li, Celgene Corporation; Peng-Liang Zhao, sanofi-aventis; Meehyung Cho, sanofi-aventis; Ji Zhang, Sanofi-Aventis; Yujun Wu, Sanofi-Aventis
10:35 AM
|
|